Clinical Trials Browser

Recruiting × Interventional × Pancreatic Cancer Resectable × Clear all

NCT06722911 2024-12-09

Study of Adjuvant Nimotuzumab Combined with Nab-paclitaxel+ Gemcitabine in EGFR-positive Pancreatic Cancer

Phase 2 Recruiting

Gastrointestinal

Pancreatic Cancer Resectable

NCT06368063 2024-05-08

The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer

Phase 4 Recruiting

Gastrointestinal

Pancreatic Cancer Resectable